ALPHATEC HOLDINGS, INC. (ATEC) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 65.01M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 510.74M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 791.03M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $65.01M | $510.74M | (m) | (m) | $791.03M | (m) |
| 2026-03-31 | (m) | (m) | $65.52M | $507.89M | (m) | (m) | $799.48M | (m) |
| 2025-12-31 | (m) | (m) | $64.53M | $501.41M | (m) | (m) | $791.21M | (m) |
| 2025-09-30 | (m) | (m) | $64.66M | $495.02M | (m) | (m) | $787.25M | (m) |
| 2025-06-30 | (m) | (m) | $1.93M | $551.99M | (m) | (m) | $790.29M | (m) |
| 2025-03-31 | (m) | (m) | $2.57M | $545.83M | (m) | (m) | $785.47M | (m) |
| 2024-12-31 | (m) | (m) | $1.66M | $574.52M | (m) | (m) | $775.71M | (m) |
| 2024-09-30 | (m) | (m) | $1.79M | $525.93M | (m) | (m) | $745.89M | (m) |
| 2024-06-30 | (m) | (m) | $2.29M | $516.88M | (m) | (m) | $768.59M | (m) |
| 2024-03-31 | (m) | (m) | $2.55M | $511.89M | (m) | (m) | $774.58M | (m) |
| 2023-12-31 | (m) | (m) | $1.81M | $511.04M | (m) | (m) | $805.21M | (m) |
| 2023-09-30 | (m) | (m) | $1.77M | $506.61M | (m) | (m) | $670.22M | (m) |
| 2023-06-30 | (m) | (m) | $2.21M | $455.34M | (m) | (m) | $628.23M | (m) |
| 2023-03-31 | (m) | (m) | $16.07M | $419.45M | (m) | (m) | $569.69M | (m) |
| 2022-12-31 | (m) | (m) | $14.95M | $349.51M | (m) | (m) | $513.38M | (m) |
| 2022-09-30 | (m) | (m) | $13.55M | $348.32M | (m) | (m) | $516.28M | (m) |
| 2022-06-30 | (m) | (m) | $14.27M | $313.40M | (m) | (m) | $511.94M | (m) |
| 2022-03-31 | (m) | (m) | $1.79M | $326.64M | (m) | (m) | $548.69M | (m) |
| 2021-12-31 | (m) | (m) | $342.00K | $326.49M | (m) | (m) | $572.05M | (m) |
| 2021-09-30 | (m) | (m) | (m) | $320.97M | (m) | (m) | $598.11M | (m) |
| 2021-06-30 | (m) | (m) | (m) | $55.79M | (m) | (m) | $441.03M | (m) |
| 2021-03-31 | (m) | (m) | $5.37M | $38.58M | (m) | (m) | $404.50M | (m) |
| 2020-12-31 | (m) | (m) | $4.20M | $38.03M | (m) | (m) | $261.22M | (m) |
| 2020-09-30 | (m) | (m) | $1.67M | $65.76M | (m) | (m) | $154.68M | (m) |
| 2020-06-30 | (m) | (m) | $399.00K | $66.07M | (m) | (m) | $161.13M | (m) |
| 2020-03-31 | (m) | (m) | $916.00K | $53.03M | (m) | (m) | $153.84M | (m) |
| 2019-12-31 | (m) | (m) | $489.00K | $53.45M | (m) | (m) | $169.95M | (m) |
| 2019-09-30 | (m) | (m) | $836.00K | $51.09M | (m) | (m) | $178.28M | (m) |
| 2019-06-30 | (m) | (m) | $286.00K | $49.37M | (m) | (m) | $133.43M | (m) |
| 2019-03-31 | (m) | (m) | $619.00K | $42.56M | (m) | (m) | $119.42M | (m) |
| 2018-12-31 | (m) | (m) | $3.28M | $42.30M | (m) | (m) | $129.48M | (m) |
| 2018-09-30 | (m) | (m) | $6.19M | $34.28M | (m) | (m) | $131.47M | (m) |
| 2018-06-30 | (m) | (m) | $6.68M | $33.67M | (m) | (m) | $139.50M | (m) |
| 2018-03-31 | (m) | (m) | $6.89M | $34.66M | (m) | (m) | $143.34M | (m) |
| 2017-12-31 | (m) | (m) | $3.31M | $37.77M | (m) | (m) | $84.66M | (m) |
| 2017-09-30 | (m) | (m) | $3.04M | $37.23M | (m) | (m) | $79.77M | (m) |
| 2017-06-30 | (m) | (m) | $2.33M | $38.18M | (m) | (m) | $84.20M | (m) |
| 2017-03-31 | (m) | (m) | $2.62M | $40.02M | (m) | (m) | $93.57M | (m) |
| 2016-12-31 | (m) | (m) | $3.11M | $43.09M | (m) | (m) | $94.19M | (m) |
| 2016-09-30 | (m) | (m) | $2.65M | $38.22M | (m) | (m) | $96.03M | (m) |
| 2016-06-30 | (m) | (m) | $75.38M | $187.00K | (m) | (m) | $136.45M | (m) |
| 2016-03-31 | (m) | (m) | $78.11M | $314.00K | (m) | (m) | $145.39M | (m) |
| 2015-12-31 | (m) | (m) | $80.11M | $480.00K | (m) | (m) | $146.70M | (m) |
| 2015-09-30 | (m) | (m) | $59.02M | $20.92M | (m) | (m) | $148.38M | (m) |
| 2015-06-30 | (m) | (m) | $6.75M | $69.78M | (m) | (m) | $314.17M | (m) |
| 2015-03-31 | (m) | (m) | $7.26M | $72.22M | (m) | (m) | $320.11M | (m) |
| 2014-12-31 | (m) | (m) | $8.08M | $74.60M | (m) | (m) | $344.92M | (m) |
| 2014-09-30 | (m) | (m) | $8.04M | $70.62M | (m) | (m) | $348.60M | (m) |
| 2014-06-30 | (m) | (m) | $5.91M | $70.91M | (m) | (m) | $364.71M | (m) |
| 2014-03-31 | (m) | (m) | $4.19M | $64.11M | (m) | (m) | $386.28M | (m) |
| 2013-12-31 | (m) | (m) | $4.92M | $49.98M | (m) | (m) | $365.63M | (m) |
| 2013-03-31 | (m) | (m) | $1.28M | $40.58M | (m) | (m) | $374.20M | (m) |
| 2012-12-31 | (m) | (m) | $1.70M | $39.97M | (m) | (m) | $382.13M | (m) |
| 2012-09-30 | (m) | (m) | $1.72M | $36.03M | (m) | (m) | $365.67M | (m) |
| 2012-06-30 | (m) | (m) | $766.00K | $35.31M | (m) | (m) | $357.05M | (m) |
| 2012-03-31 | (m) | (m) | $3.65M | $26.65M | (m) | (m) | $364.68M | (m) |
| 2011-12-31 | (m) | (m) | $4.40M | $23.80M | (m) | (m) | $366.69M | (m) |
| 2011-09-30 | (m) | (m) | $2.54M | $28.77M | (m) | (m) | $372.69M | (m) |
| 2011-06-30 | (m) | (m) | $963.00K | $32.22M | (m) | (m) | $384.45M | (m) |
| 2010-12-31 | (m) | (m) | $1.71M | $32.47M | (m) | (m) | $377.02M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |